GLP‑1 Weight‑Loss Drugs Spark Interest in Cadaver Fat Injections

GLP‑1 medications are known for causing significant weight loss in patients. The rapid shrinking of bodies has prompted discussions about cosmetic restoration. A niche market is exploring the use of cadaver‑derived fat injections to restore volume. The concept involves transplanting preserved human fat into areas of loss. Proponents argue it could offer a quick solution for those seeking fuller contours. Critics raise ethical and safety concerns about using cadaver tissue. Regulatory bodies have not yet issued formal guidance on the practice. The debate highlights broader questions about post‑weight‑loss body management.